{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:08:15Z","timestamp":1793689695102,"version":"4.5.1"},"reference-count":20,"publisher":"The Japanese Society for Medical Mycology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2023]]},"DOI":"10.3314\/mmj.22-00025","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T18:20:41Z","timestamp":1685470841000},"page":"37-43","source":"Crossref","is-referenced-by-count":9,"title":["Kerion Celsi due to <i>Microsporum canis<\/i> in an Adult Woman, Treated Successfully with Fosravuconazole"],"prefix":"10.3314","volume":"64","author":[{"given":"Harunari","family":"Shimoyama","sequence":"first","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"},{"name":"Teikyo University Institute of Medical Mycology (TIMM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Taira","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Satoh","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology (TIMM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology (TIMM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Yo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"},{"name":"Teikyo University Institute of Medical Mycology (TIMM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Sei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Makimura","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology (TIMM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kuwano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Leung AKC, Hon KL, Leong KF, Barankin B, Lam JM: Tinea capitis: an updated review. Recent Pat Inflamm Allergy Drug Discov 14: 58–68, 2020.","DOI":"10.2174\/1872213X14666200106145624"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gupta AK, Friedlander SF, Simkovich AJ: Tinea capitis: an update. Pediatr Dermatol 39: 167–172, 2022.","DOI":"10.1111\/pde.14925"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) John AM, Schwartz RA, Janniger CK: The kerion: an angry tinea capitis. Int J Dermatol 57: 3–9, 2018.","DOI":"10.1111\/ijd.13423"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mochizuki T, Tsuboi R, Iozumi K, et al: Guidelines for the management of dermatomycosis (2019). J Dermatol 47: 1343–1373, 2020.","DOI":"10.1111\/1346-8138.15618"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Watanabe S, Tsubouchi I, Okubo A: Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: a multicenter, double-blind, randomized phase III study. J Dermatol 45: 1151–1159, 2018.","DOI":"10.1111\/1346-8138.14607"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mikamo H, Yin XH, Hayasaki Y, Shimamura Y, Uesugi K, Fukayama N, Satoh M, Tamaya T: Penetration of ravuconazole, a new triazole antifungal, into rat tissues. Chemotherapy 48: 7–9, 2002.","DOI":"10.1159\/000048580"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yamaguchi H: Potential of ravuconazole and its prodrugs as the new oral therapeutics for onychomycosis. Med Mycol J 57: E93–E110, 2016.","DOI":"10.3314\/mmj.16-00006"},{"key":"8","unstructured":"8) Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yang Z, Chen W, Wan Z, Song Y, Li R: Tinea capitis by Microsporum canis<\/i> in an elderly female with extensive dermatophyte infection. Mycopathologia 186: 299–305, 2021.","DOI":"10.1007\/s11046-020-00519-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM: British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol 171: 454–463, 2014.","DOI":"10.1111\/bjd.13196"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Aste N, Pau M, Biggio P: Tinea capitis in adults. Mycoses 39: 299–301, 1996.","DOI":"10.1111\/j.1439-0507.1996.tb00142.x"},{"key":"12","unstructured":"12) El-Khalawany M, Shaaban D, Hassan H, Abdalsalam F, Eassa B, Kader A, Shaheen I: A multicenter clinicomycological study evaluating the spectrum of adult tinea capitis in Egypt. Acta Dermatovenerol Alp Pannonica Adriat 22: 77–82, 2013."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Park SK, Park SW, Yun SK, Kim HU, Park J: Tinea capitis in adults: a 18-year retrospective, single-centre study in Korea. Mycoses 62: 609–616, 2019.","DOI":"10.1111\/myc.12916"},{"key":"14","unstructured":"14) Parry RL: Woman dies after taking tablet tainted with sleeping drug. The TIMES. 2020. https:\/\/www.thetimes.co.uk\/article\/woman-dies-after-taking-tablet-tainted-with-sleeping-drug-csqx6ghp3 (Accessed 12 Sep 2022)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Noguchi H, Matsumoto T, Kimura U, Hiruma M, Kano R, Kubo M, Fukushima S, Ihn H: Fosravuconazole to treat severe onychomycosis in the elderly. J Dermatol 48: 228–231, 2021.","DOI":"10.1111\/1346-8138.15651"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Shimoyama H, Yo A, Sei Y, Kuwano Y: Treatment outcome with fosravuconazole for onychomycosis. Mycopathologia 186: 259–267, 2021.","DOI":"10.1007\/s11046-021-00540-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Miyata A, Kimura U, Noguchi H, Matsumoto T, Hiruma M, Kano R, Takamori K, Suga Y: Tinea capitis caused by Trichophyton violaceum<\/i> successfully treated with fosravuconazole. J Dermatol 48: e331–e332, 2021.","DOI":"10.1111\/1346-8138.15901"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kitauchi Y, Kumagai Y, Inoue-Masuda Y, Sugiura M, Sato T, Yaguchi T, Yokoyama T: Tinea corporis caused by terbinafine-resistant Trichophyton rubrum<\/i> successfully treated with fosravuconazole. J Dermatol 48: e329–e330, 2021.","DOI":"10.1111\/1346-8138.15900"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Takeshima R, Asahina Y, Yaguchii T, Sato T: Tinea barbae due to Trichophyton rubrum<\/i> successfully treated using oral fosravuconazole l-lysine ethanolate. J Dermatol 47: e254–e255, 2020.","DOI":"10.1111\/1346-8138.15374"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Suzuki T, Sato T, Kasuya A, Yaguchi T: A case of tinea faciei, tinea corporis, and tinea unguium with dermatophytoma successfully treated with oral fosravuconazole l-lysine ethanolate. Med Mycol J 62: 1–4, 2021.","DOI":"10.3314\/mmj.20-00015"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/64\/2\/64_37\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T01:06:17Z","timestamp":1715303177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/64\/2\/64_37\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.22-00025","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}